![](/img/cover-not-exists.png)
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
Chugh, R., Griffith, K. A., Davis, E. J., Thomas, D. G., Zavala, J. D., Metko, G., Brockstein, B., Undevia, S. D., Stadler, W. M., Schuetze, S. M.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv171
Date:
April, 2015
File:
PDF, 276 KB
english, 2015